Study Immunology and Safety of 60-day Treatment of SQ Grass SLIT (Sublingual Immunotherapy)-Tablet in Adult Subjects With Grass Pollen-induced Allergic Rhinoconjunctivitis

NCT02245360 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

107

Enrollment

INDUSTRY

Sponsor class

Conditions

Seasonal Allergic Rhinitis

Interventions

DRUG: Phleum pratense grass pollen allergen extract
DRUG: placebo

Sponsor

Abbott